Sarah E. Poplawski

1.2k total citations
14 papers, 852 citations indexed

About

Sarah E. Poplawski is a scholar working on Oncology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Sarah E. Poplawski has authored 14 papers receiving a total of 852 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 5 papers in Molecular Biology and 5 papers in Cellular and Molecular Neuroscience. Recurrent topics in Sarah E. Poplawski's work include Peptidase Inhibition and Analysis (10 papers), Neuropeptides and Animal Physiology (5 papers) and Protease and Inhibitor Mechanisms (3 papers). Sarah E. Poplawski is often cited by papers focused on Peptidase Inhibition and Analysis (10 papers), Neuropeptides and Animal Physiology (5 papers) and Protease and Inhibitor Mechanisms (3 papers). Sarah E. Poplawski collaborates with scholars based in United States. Sarah E. Poplawski's co-authors include William W. Bachovchin, Jack H. Lai, David G. Sanford, Daniel A. Bachovchin, Marian C. Okondo, Darren C. Johnson, Ashley J. Chui, Wengen Wu, Achilles Athanassiou and Jill Donelan and has published in prestigious journals such as The Journal of Immunology, Cancer Research and Journal of Medicinal Chemistry.

In The Last Decade

Sarah E. Poplawski

14 papers receiving 845 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sarah E. Poplawski United States 10 475 277 269 111 104 14 852
Hiroko Kishikawa United States 17 445 0.9× 124 0.4× 396 1.5× 53 0.5× 101 1.0× 29 1.1k
Gabriele Matthias Switzerland 9 1.2k 2.5× 346 1.2× 146 0.5× 54 0.5× 64 0.6× 11 1.4k
Evelyn Aranda United States 11 412 0.9× 210 0.8× 106 0.4× 37 0.3× 126 1.2× 12 753
Nathan D. Camp United States 15 908 1.9× 143 0.5× 95 0.4× 31 0.3× 55 0.5× 21 1.1k
Cheryl Li United States 11 383 0.8× 189 0.7× 168 0.6× 20 0.2× 79 0.8× 23 838
Patricia A. Zipfel United States 16 596 1.3× 283 1.0× 169 0.6× 24 0.2× 75 0.7× 21 1.0k
Gabriela Schneider United States 23 729 1.5× 197 0.7× 189 0.7× 15 0.1× 177 1.7× 55 1.1k
Francesca Capotosti Switzerland 8 386 0.8× 225 0.8× 286 1.1× 97 0.9× 16 0.2× 17 809
William Gillespie United States 12 395 0.8× 52 0.2× 181 0.7× 74 0.7× 58 0.6× 20 667
William Köhler United States 12 472 1.0× 314 1.1× 55 0.2× 59 0.5× 88 0.8× 19 1.0k

Countries citing papers authored by Sarah E. Poplawski

Since Specialization
Citations

This map shows the geographic impact of Sarah E. Poplawski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah E. Poplawski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah E. Poplawski more than expected).

Fields of papers citing papers by Sarah E. Poplawski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah E. Poplawski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah E. Poplawski. The network helps show where Sarah E. Poplawski may publish in the future.

Co-authorship network of co-authors of Sarah E. Poplawski

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah E. Poplawski. A scholar is included among the top collaborators of Sarah E. Poplawski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah E. Poplawski. Sarah E. Poplawski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Poplawski, Sarah E., Robin Hallett, Shuang Pan, et al.. (2023). Preclinical Development of PNT6555, a Boronic Acid–Based, Fibroblast Activation Protein-α (FAP)–Targeted Radiotheranostic for Imaging and Treatment of FAP-Positive Tumors. Journal of Nuclear Medicine. 65(1). 100–108. 20 indexed citations
2.
McLaughlin, F. A., Sarah E. Poplawski, David G. Sanford, et al.. (2022). Abstract 1815: AVA6000, a novel Precision medicine, targeted to the tumor microenvironment via Fibroblast Activation Protein (FAP) mediated cleavage. Cancer Research. 82(12_Supplement). 1815–1815. 5 indexed citations
3.
Hallett, Robin, Sarah E. Poplawski, Shin Hye Ahn, et al.. (2022). Abstract 3303: Pre-clinical characterization of the novel FAP targeting ligand PNT6555 for imaging and therapy of cancer. Cancer Research. 82(12_Supplement). 3303–3303. 4 indexed citations
4.
Okondo, Marian C., Sahana D. Rao, Cornelius Y. Taabazuing, et al.. (2018). Inhibition of Dpp8/9 Activates the Nlrp1b Inflammasome. Cell chemical biology. 25(3). 262–267.e5. 145 indexed citations
5.
Okondo, Marian C., Darren C. Johnson, Ramya Sridharan, et al.. (2016). DPP8 and DPP9 inhibition induces pro-caspase-1-dependent monocyte and macrophage pyroptosis. Nature Chemical Biology. 13(1). 46–53. 226 indexed citations
6.
Bachovchin, Daniel A., Luke W. Koblan, Wengen Wu, et al.. (2014). A high-throughput, multiplexed assay for superfamily-wide profiling of enzyme activity. Nature Chemical Biology. 10(8). 656–663. 60 indexed citations
7.
Poplawski, Sarah E., Jack H. Lai, Youhua Li, et al.. (2013). Identification of Selective and Potent Inhibitors of Fibroblast Activation Protein and Prolyl Oligopeptidase. Journal of Medicinal Chemistry. 56(9). 3467–3477. 88 indexed citations
8.
Wu, Wengen, Yuxin Liu, Peng Zhao, et al.. (2012). 4-Substituted boro-proline dipeptides: Synthesis, characterization, and dipeptidyl peptidase IV, 8, and 9 activities. Bioorganic & Medicinal Chemistry Letters. 22(17). 5536–5540. 10 indexed citations
9.
Poplawski, Sarah E., et al.. (2011). Pro-Soft Val-boroPro: A Strategy for Enhancing in Vivo Performance of Boronic Acid Inhibitors of Serine Proteases. Journal of Medicinal Chemistry. 54(7). 2022–2028. 20 indexed citations
10.
Lai, Jack H., Wengen Wu, Yuxin Liu, et al.. (2011). Chemical and Biological Evaluation of Dipeptidyl Boronic Acid Proteasome Inhibitors for Use in Prodrugs and Pro-Soft Drugs Targeting Solid Tumors. Journal of Medicinal Chemistry. 54(13). 4365–4377. 70 indexed citations
11.
Lai, Jack H., Wengen Wu, Yuhong Zhou, et al.. (2007). Synthesis and Characterization of Constrained Peptidomimetic Dipeptidyl Peptidase IV Inhibitors:  Amino-Lactam boroAlanines. Journal of Medicinal Chemistry. 50(10). 2391–2398. 13 indexed citations
12.
Lai, Jack H., Yuhong Zhou, James L. Sudmeier, et al.. (2005). Microscopic Acid-Base Equilibra of Alanyl-boroAlanine. Kluwer Academic Publishers eBooks. 524. 333–338. 2 indexed citations
13.
Kandere‐Grzybowska, Kristiana, Richard Létourneau, Duraisamy Kempuraj, et al.. (2003). IL-1 Induces Vesicular Secretion of IL-6 without Degranulation from Human Mast Cells. The Journal of Immunology. 171(9). 4830–4836. 185 indexed citations
14.
Poon, Thomas, Leah R. Eller, Andrea E. Dorigo, et al.. (1999). The Preparation of a UV-Light-Absorbing Polymer: A Project-Oriented Laboratory Experiment for the Introductory Organic Chemistry Curriculum. Journal of Chemical Education. 76(11). 1523–1523. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026